She previously led clinical development programs in cystic fibrosis and multiple sclerosis at Vertex and ... and geopolitical conflicts; and the other factors discussed under the heading “Risk Factors ...

Clene's cash, cash equivalents and marketable securities totaled $14.6 million as of September 30, 2024, compared to $35.0 million as of December 31, 2023. Clene expects that its resources as of ...

The only current treatment option is a strict, lifelong gluten-free diet, which poses significant challenges due to dietary and social restrictions and the risk of cross-contamination ... relapsing ...

President and CEO: Jake Allen - Goldman Sachs: Sung Ji Nam - Scotiabank: Kyle Mikson - Canaccord Genuity: Puneet Souda - ...

Several solid-tumor-specific factors hinder progress ... For example, in diseases like systemic lupus erythematosus or ...

Initiated the Phase 2 MoonStone trial, a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial, to evaluate the efficacy and safety of obexelimab in patients with Relapsing Multiple ...

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...

There is no shortage of ASX healthcare companies with upcoming catalysts – a focal point for investors. ... Read More The ...

Two enzymes in brain cells are responsible for mediating the toxic effects of certain fat molecules in multiple sclerosis, ...

Demyelinating optic neuritis (DON) is a hallmark feature of multiple sclerosis (MS ... effect seems to be lost after 2 years. The risk of developing MS following DON can be stratified based ...

I think the driving factor of this thesis with the greatest weight to my buy case is the firm's diversified pipeline of drugs ...